| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ANKRD12_0013900 | Exon-Exon | chr18:9256228-9281591 | chr18:9256230-9281593 | 250 nt | 0.2240 |
| hsa_chr18_0229400 | Intergenic-Intergenic | chr18:9256288-9256529 | chr18:9256290-9256531 | 242 nt | 0.3140 |
| hsa_ANKRD12_0014000 | Exon-Exon | chr18:9256528-9279642 | chr18:9256530-9279644 | 2741 nt | 0.3827 |
| hsa_ANKRD12_0014100 | Exon-Exon | chr18:9257689-9257823 | chr18:9257691-9257825 | 135 nt | 0.4519 |
| hsa_chr18_0229500 | Intergenic-Intergenic | chr18:9257761-9281354 | chr18:9257763-9281356 | 1924 nt | 0.3659 |
| hsa_ANKRD12_0014500 | Exon-Exon | chr18:9263788-9279642 | chr18:9263790-9279644 | 102 nt | 0.3333 |
| hsa_ANKRD12_0014400 | Exon-Exon | chr18:9263788-9281126 | chr18:9263790-9281128 | 527 nt | 0.3966 |
| hsa_ANKRD12_0014600 | Exon-Exon | chr18:9263788-9282763 | chr18:9263790-9282765 | 331 nt | 0.3958 |
| hsa_ANKRD12_0014700 | Intron-Exon-Intron | chr18:9271900-9275665 | chr18:9271902-9275667 | 71 nt | 0.4507 |
| hsa_ANKRD12_0014800 | Intron-Exon-Intron | chr18:9271900-9279642 | chr18:9271902-9279644 | 96 nt | 0.3438 |
A study in humans demonstrated that circANKRD12 circANKRD12 was significantly upregulated in the peripheral blood of myocardial infarction patients compared to healthy controls, with RT-qPCR validation showing high diagnostic efficacy as reflected by an area under the curve of 0.7819 in receiver operating characteristic analysis [Li et al. DOI:10.3389/fcvm.2022.810257]. A study in humans demonstrated that the circANKRD12 was identified as a differentially expressed circular RNA in the peripheral blood of myocardial infarction patients and was confirmed in an AC16 cell model [Tian et al. DOI: 10.3390/molecules26041155].